FIELD: medicine, pharmaceutics.
SUBSTANCE: declared invention refers to chemical-pharmaceutical industry, and concerns pharmaceutical compositions effective particularly in treating motor fluctuations taking L-dopa for treating Parkinson's disease and containing a subacid material representing edible acid or a combination of edible acids providing the pH value of the composition within 5.5-6.5 and a pharmacologically effective amount of micronised L-dopa as an active ingredient in which the active ingredient is found as particles on a surface of larger particles of the carrier.
EFFECT: preparation of new pharmaceutical compositions for treating Parkinson's disease.
38 cl, 4 ex, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| IMMEDIATE-ACTION PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2345791C2 |
| FENTANYL COMPOSITION FOR TREATMENT OF ACUTE PAIN | 1999 |
|
RU2232580C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING ACUTE DISORDERS | 1999 |
|
RU2193879C1 |
| METHOD FOR TREATMENT OF PARKINSON'S DISEASE | 2014 |
|
RU2677278C2 |
| HYDROPHILIC PRESSURE-SENSITIVE BIOADHESIVE WITH TARGETED ADHESION TOWARDS TEETH AND DENTAL CARE COMPOSITION BASED THEREON | 2012 |
|
RU2517142C2 |
| COMBINATION OF RILUSOL AND L-DOFA FOR TREATING PARKINSON'S DISEASE | 1999 |
|
RU2225204C2 |
| COMPOSITION COMPRISING L-DOPA TRANSFER BLOCKING AGENTS IN RENAL CELLS AND THEIR USING IN TREATMENT OF PARKINSON'S DISEASE | 2001 |
|
RU2266111C2 |
| DRUG PREPARATION FOR PARKINSON DISEASE | 2014 |
|
RU2545734C1 |
| COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING BETA-AMYLOID DISEASES AND SYNUCLEINOPATHIES | 2009 |
|
RU2501792C2 |
| SALTS OF PIPERAZINE DERIVATIVE WITH SALICYLIC AND GENTISIC ACID | 2006 |
|
RU2412184C2 |
